Related references
Note: Only part of the references are listed.Role of Globotriaosylceramide in Physiology and Pathology
Ana Beatriz Celi et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli
Jorge Goldstein et al.
CURRENT NEUROPHARMACOLOGY (2021)
The Protein Toxins Ricin and Shiga Toxin as Tools to Explore Cellular Mechanisms of Internalization and Intracellular Transport
Kirsten Sandvig et al.
TOXINS (2021)
Pathogenic functions and diagnostic utility of cytokines/chemokines in EHEC-HUS
Masaki Shimizu
PEDIATRICS INTERNATIONAL (2020)
Anti-human CD63 monoclonal antibody COS3A upregulates monocyte-induced IL-10 excretion leading to diminution of CD3-mediated T cell response
Siriwan Wansook et al.
MOLECULAR IMMUNOLOGY (2019)
Shiga toxin 2 from enterohemorrhagic Escherichia coli induces reactive glial cells and neurovascular disarrangements including edema and lipid peroxidation in the murine brain hippocampus
Clara Berdasco et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome
Laura F. Alconcher et al.
PEDIATRIC NEPHROLOGY (2018)
Anti-inflammatory agents reduce microglial response, demyelinating process and neuronal toxin uptake in a model of encephalopathy produced by Shiga Toxin 2
Alipio Pinto et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2018)
DEXAMETHASONE PREVENTS MOTOR DEFICITS AND NEUROVASCULAR DAMAGE PRODUCED BY SHIGA TOXIN 2 AND LIPOPOLYSACCHARIDE IN THE MOUSE STRIATUM
Alipio Pinto et al.
NEUROSCIENCE (2017)
Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation
Mahban Rahimifard et al.
AGEING RESEARCH REVIEWS (2017)
Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012
N. Launders et al.
BMJ OPEN (2016)
Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease
Suman Pradhan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Recovery of thalamic microstructural damage after Shiga toxin 2-associated hemolytic uremic-syndrome
Julia Kraemer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
The Blood-Brain Barrier
Richard Daneman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Upregulation of Shiga Toxin Receptor CD77/Gb3 and Interleukin-1β Expression in the Brain of EHEC Patients with Hemolytic Uremic Syndrome and Neurologic Symptoms
Christian Hagel et al.
BRAIN PATHOLOGY (2015)
Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2
Sven G. Meuth et al.
ANNALS OF NEUROLOGY (2013)
A Translational Murine Model of Sub-Lethal Intoxication with Shiga Toxin 2 Reveals Novel Ultrastructural Findings in the Brain Striatum
Carla Tironi-Farinati et al.
PLOS ONE (2013)
Dexamethasone Rescues Neurovascular Unit Integrity from Cell Damage Caused by Systemic Administration of Shiga Toxin 2 and Lipopolysaccharide in Mice Motor Cortex
Alipio Pinto et al.
PLOS ONE (2013)
The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak
Tim Magnus et al.
BRAIN (2012)
Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults
Karin Weissenborn et al.
NEUROLOGY (2012)
Shiga Toxin 1 Induces on Lipopolysaccharide-Treated Astrocytes the Release of Tumor Necrosis Factor-alpha that Alter Brain-Like Endothelium Integrity
Veronica I. Landoni et al.
PLOS PATHOGENS (2012)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
NeuN/Fox-3 is an intrinsic component of the neuronal nuclear matrix
Myrna A. R. Dent et al.
FEBS LETTERS (2010)
Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing Factors
Kee K. Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains
Javier Boccoli et al.
BRAIN RESEARCH (2008)
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons
Fumiko Obata et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The thalamus is more than just a relay
S. Murray Sherman
CURRENT OPINION IN NEUROBIOLOGY (2007)
The endothelial glycocalyx: a potential barrier between health and vascular disease
M Nieuwdorp et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease
GM Halliday et al.
BRAIN (2005)
An interventional approach to block brain damage caused by Shiga toxin-producing Escherichia coli infection, by use of a combination of phosphodiesterase inhibitors
A Okayama et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Functional anatomy of thalamus and basal ganglia
MT Herrero et al.
CHILDS NERVOUS SYSTEM (2002)
Therapeutic effect of anti-TNF-α antibody and levofloxacin (LVFX) in a mouse model of enterohemorrhagic Escherichia coli O157 infection
E Isogai et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2001)
Capillary endothelial surface layer selectively reduces plasma solute distribution volume
H Vink et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)